CO suppresses prostate cancer cell growth by directly targeting LKB1/AMPK/mTOR pathway in vitro and in vivo
Related Experiment Video
Updated: Feb 12, 2026

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples
Published on: March 14, 2014
Yutao Yan1, Caiqi Du2, Guohao Li3
1Institute of Organ, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan China; Key Laboratory of Organ Transplantation, Ministry of Health, China; Key Laboratory of Organ Transplantation, Ministry of Education, China.
Background:
CO is a freely diffusible gas that acts as a physiological mediator of many biological and cellular processes, which has been shown to possess anticancer effect in many kinds of cancers. However, the effect of CO on prostate cancer has not been demonstrated. Therefore, we analyzed the antitumor activities and related mechanisms of CO on prostate cancer in vitro and in vivo.
Methods:
Cell viability of LNCaP and PC-3 cells after CORM-2 treatment was measured by CCK-8 assay, whereas the ATP production were detected by ATP detection assay. The early apoptosis induced by CO was evaluated by flow cytometry, and the expression level of apoptosis-related molecules (Caspases 3, 8, 9 and cleaved-Caspases 3, 8, 9) was detected using Western blot. Matrigel in vitro invasion assay was used to evaluate the effect of CO on cell invasion. We then evaluated the impact of CO on the expression of several key regulators involved in the LKB1 signaling pathway. At last, xenograft tumor in nude mice was used to further investigate the antitumor effect of CO in vivo.
Results:
Our results showed that CO could significantly inhibit proliferation and invasion, and induce apoptosis in human prostate cancer cell lines. The expression of LKB1 could be up-regulated after CO treatment, and CO also could increase p-AMPK levels and decrease p-mTOR. Furthermore, LKB1 knockdown could weaken the effect of CO on prostate cancer cells. In vivo, CO treatment significantly suppressed tumor growth and induced apoptosis in xenografts tumor in nude mice.
Conclusions:
CO possesses striking anticancer effect in human prostate cancer cells in vitro and in vivo, which is largely mediated by LKB1-AMPK-mTOR axis.
Insights
Carbon monoxide (CO) demonstrates significant anticancer effects in prostate cancer cells by inhibiting proliferation and invasion. This action is primarily mediated through the LKB1-AMPK-mTOR signaling pathway, impacting tumor growth both in vitro and in vivo.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Carbon monoxide (CO) is a gasotransmitter with known anticancer properties in various cancer types.
- The specific effects and underlying mechanisms of CO on prostate cancer remain largely unexplored.
- This study investigates the antitumor potential of CO in prostate cancer models.
Purpose of the Study:
- To evaluate the anticancer activities of CO in human prostate cancer cell lines (LNCaP and PC-3) in vitro.
- To elucidate the molecular mechanisms by which CO exerts its antitumor effects, focusing on the LKB1 signaling pathway.
- To assess the efficacy of CO in suppressing prostate cancer growth in a preclinical in vivo model.
Main Methods:
- Cell viability and ATP production assays (CCK-8) were used to assess proliferation.
- Flow cytometry and Western blotting were employed to evaluate apoptosis and related protein expression (Caspases).
- In vitro invasion assays and in vivo xenograft tumor models were utilized to determine CO's impact on tumor invasion and growth.
Main Results:
- CO significantly inhibited prostate cancer cell proliferation and invasion while inducing apoptosis.
- CO treatment upregulated LKB1 expression, increased p-AMPK levels, and decreased p-mTOR.
- LKB1 knockdown diminished CO's antitumor effects, and CO suppressed tumor growth in vivo.
Conclusions:
- Carbon monoxide exhibits potent anticancer effects against human prostate cancer cells.
- The observed antitumor activity is largely mediated by the LKB1-AMPK-mTOR signaling pathway.
- CO represents a promising therapeutic agent for prostate cancer treatment.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Targeted Cancer Therapies
There are several types of targeted therapies against...
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
Equivalence: In Vitro and In Vivo Bioequivalence
Cells Coordinate Growth and Proliferation

